Barbara M. Wirostko
( out of 249 reviews )

Barbara M. Wirostko, MD

Languages spoken: English

Clinical Locations

  • John A. Moran Eye Center

    801-581-2352

  • Redstone Health Center

    435-658-9250

  • Barbara M. Wirostko, MD, FARVO, is Moran’s Resident Research Director and Adjunct Professor of Ophthalmology and Biomedical Engineering. She has specialized fellowship training in glaucoma, is a board-certified ophthalmologist, and a Fellow of The Association of Research in Vision and Ophthalmology (ARVO).

    She treats glaucoma and comprehensive ophthalmology patients, specializes in clinical research, and advises drug development for glaucoma pharmaceutical therapies. As a serial entrepreneur for biotech startups, she has received millions in grants as the principal investigator (PI) for funding from the Department of Defense and National Science Foundation.

    Her research interest is in novel glaucoma therapeutics, sustained delivery of therapeutics for ocular pathologies, and better understanding the genetics and associated systemic diseases of exfoliative syndrome, a common cause of open-angle glaucoma.

    Dr. Wirostko has scored in the top 10 percent nationwide for patient satisfaction. Her honors include Moran’s Clinical Faculty of the Year Award in 2015 and the Third Annual Distinguished Alumni Award from the Edward S. Harkness Eye Institute, Columbia University.

    Her professional and scientific experience includes serving as associate editor for Ophthalmology Glaucoma, Acta Ophthalmologica, and Journal of Glaucoma. She’s an active committee member for ARVO and a scientific advisor for the California Institute of Regenerative Medicine, The Glaucoma Foundation, and the Glaucoma Research Foundation.

    Dr. Wirostko’s numerous grants include a new two-year project funded by a BrightFocus Foundation National Glaucoma Research award of nearly $180,000. The research project, “Prognostic Factors and Predictive Markers of Progression to Exfoliation Glaucoma in Exfoliation Syndrome,” will include a multi-disciplinary team of experts. She will serve as co-PI with Karen Curtin, PhD, MStat, with the Utah Population Database.

    Specialties

    • Glaucoma
    • Ophthalmology

    Patient Rating

    4.9 /5
    ( out of 249 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    February 11, 2023

    Dr. Wirostko sensed that I was concerned about the difficulty making certain my evaluation was complete and spent her time making it clear about the importantly normal aspects of my sight. There was never a feeling that she had limited time for my evaluation and treatment.

    February 10, 2023

    Dr Wirostko has been an outstanding partner in helping me navigate some difficult challenges with my eye health. Her personalized focus is greatly appreciated.

    February 03, 2023

    Thank you! She was wonderful explaining what was going on and including me in care options!

    See More Patient Comments

  • Barbara M. Wirostko, MD, FARVO, is Moran’s Resident Research Director and Adjunct Professor of Ophthalmology and Biomedical Engineering. She has specialized fellowship training in glaucoma, is a board-certified ophthalmologist, and a Fellow of The Association of Research in Vision and Ophthalmology (ARVO).

    She treats glaucoma and comprehensive ophthalmology patients, specializes in clinical research, and advises drug development for glaucoma pharmaceutical therapies. As a serial entrepreneur for biotech startups, she has received millions in grants as the principal investigator (PI) for funding from the Department of Defense and National Science Foundation.

    Her research interest is in novel glaucoma therapeutics, sustained delivery of therapeutics for ocular pathologies, and better understanding the genetics and associated systemic diseases of exfoliative syndrome, a common cause of open-angle glaucoma.

    Dr. Wirostko has scored in the top 10 percent nationwide for patient satisfaction. Her honors include Moran’s Clinical Faculty of the Year Award in 2015 and the Third Annual Distinguished Alumni Award from the Edward S. Harkness Eye Institute, Columbia University.

    Her professional and scientific experience includes serving as associate editor for Ophthalmology Glaucoma, Acta Ophthalmologica, and Journal of Glaucoma. She’s an active committee member for ARVO and a scientific advisor for the California Institute of Regenerative Medicine, The Glaucoma Foundation, and the Glaucoma Research Foundation.

    Dr. Wirostko’s numerous grants include a new two-year project funded by a BrightFocus Foundation National Glaucoma Research award of nearly $180,000. The research project, “Prognostic Factors and Predictive Markers of Progression to Exfoliation Glaucoma in Exfoliation Syndrome,” will include a multi-disciplinary team of experts. She will serve as co-PI with Karen Curtin, PhD, MStat, with the Utah Population Database.

    Education history

    Fellowship Glaucoma - The New York Hospital, Cornell Medical Center Fellow
    Ophthalmology - Columbia Presbyterian Medical Center, Edward S. Harkness Eye Institute Resident
    Internship Hackensack Medical Center Intern
    Medicine - Columbia University M.D.
    Undergraduate Microbiology - Cornell University B.A.

  • Podcasts & News

    News